HOME >> MEDICINE >> NEWS
Cedars-Sinai researchers demonstrate a new way to switch therapeutic genes 'on' and 'off'

A gene therapy research team at Cedars-Sinai Medical Center has developed a new method of signaling therapeutic genes to turn "off" or "on," a mechanism that could enable scientists to fine-tune genetic- and stem cell-based therapies so that they are safer, more controllable and more effective.

Although other similar signaling systems have been developed, the Cedars-Sinai research is the first to give physicians the flexibility to arbitrarily turn the gene expression on or off even in the presence of an immune response to adenovirus, as would be present in most patients undergoing clinical trials. This has been a major obstacle in bringing the testing of genetic therapies to humans in a clinical setting.

As reported in a study published in the January issue of the Journal of Virology, the development of a new delivery system that can more effectively regulate therapeutic gene expression has important implications for efforts to advance gene and stem cell therapy strategies that may ultimately be used to treat life-threatening neurodegenerative diseases in the clinical setting. The study, which involved laboratory rats, focused on the area of the brain that has already been the target for research into genetic therapies for Parkinson's disease.

"Since some diseases treated with gene therapy will require constant therapeutic expression while others may have periods of remission and therefore only require treatment during 'active' disease states, a system that can more closely monitor the 'how much' and 'when' the therapeutic gene is produced is a critically important tool in the development of gene therapy treatments that could help people suffering from Parkinson's and other diseases," said Maria Castro, Ph.D., co-director of the Board of Governors' Gene Therapeutic Research Institute at Cedars-Sinai and lead author of the study.

"Until now, researchers working to develop successful gene therapy for diseases such as Parkinson's hav
'"/>

Contact: Simi Singer
simi.singer@cshs.org
310-423-4768
Cedars-Sinai Medical Center
22-Dec-2005


Page: 1 2 3

Related medicine news :

1. Cedars-Sinai researchers present new endocrine findings at 2 international conferences
2. Cedars-Sinai endocrine researchers to discuss gene that may be linked to polycystic ovary syndrome
3. Obesity leads to more aggressive ovarian cancer, Cedars-Sinai research shows
4. Pauletta and Denzel Washington to present Cedars-Sinai neuroscience scholarships June 7
5. Cedars-Sinai researchers discover treatment for deadly brain tumors and infections
6. Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai
7. Cedars-Sinai medical tipsheet for December 2005
8. Cedars-Sinais live donor liver transplant program receives unos-approved designation
9. Cedars-Sinai medical tipsheet for June 2005
10. Stanford researchers find culprit in aging muscles that heal poorly
11. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 02, 2020 , ... Temprian, a spinoff from ... Its lead indication is vitiligo. Vitiligo patients develop progressive depigmentation of the ... While vitiligo is equally prevalent in all ethnic groups, it is most visible ...
(Date:7/2/2020)... ... , ... Allegheny Health Network (AHN) today announced that John S. Lee, MD, ... Dr. Lee succeeds Robert White, MD, who announced his plans for retirement earlier ... to help support a seamless transition. , Dr. Lee joins AHN from Edward-Elmhurst Healthcare, ...
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an industry leader in ... new terpene infused product line including custom rolling papers, cones, flat wraps, ... profiles and flavors worldwide. , “We’ve made it easier than ever for brands ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... today that it has been selected by Codiak BioSciences to support its cleanroom ... will provide the cleanroom infrastructure for the drug substance and product manufacturing for ...
(Date:6/28/2020)... BOSTON (PRWEB) , ... June 26, 2020 , ... PathAI, ... that the results of an exploratory analysis of digital scoring of PD-L1 expression to ... as a poster #2017 at the 2020 American Association for Cancer Research (AACR) Annual ...
Breaking Medicine News(10 mins):
(Date:7/7/2020)... ... July 07, 2020 , ... CHESS Health, the ... the leading comprehensive platform for online education on mental health, substance use, and ... Substance Use Disorder (SUD) patients throughout each step of the treatment process. , ...
(Date:7/7/2020)... ... July 07, 2020 , ... With projects ranging ... residents, the 33 nonprofits who received the latest ISA Foundation grants ... funding, the foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) nonprofit organizations. ...
(Date:7/4/2020)... ... July 03, 2020 , ... With joyful celebrations, since ... at approved capacities, reactivating the state's economy. The government health authorities' protocols have ... The most recent opening was beautiful Hacienda Tres Ríos Resort, Spa & Nature ...
Breaking Medicine Technology:
Cached News: